Ignite Creation Date:
2024-05-06 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05210504
Status:
COMPLETED
Last Update Posted:
2024-06-05
First Post:
2022-01-13
Brief Title:
Determinants of Alpha-aminoadipic Acid 2-AAA and Relationship to Diabetes Study 3
Sponsor:
Vanderbilt University Medical Center
Organization:
Vanderbilt University Medical Center
Study Overview
Official Title:
Determinants of Alpha-aminoadipic Acid 2-AAA and Relationship to Diabetes Study 3
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to assess the effect and breakdown of lysine administration specifically examining whether it leads to increased plasma 2-AAA in healthy humans
Detailed Description:
The purpose of this study is to investigate a novel biomarker α-aminoadipic acid 2-AAA which may influence the risk of diabetes 2-AAA has been identified as a novel predictor of diabetes development in humans identifying at-risk individuals before any detectable glucose abnormalities 2-AAA is a naturally occurring metabolite in the body and it has no known adverse effects at normal physiological levels 2-AAA is generated in the body from the breakdown of lysine Lysine is one of the twenty essential amino acids meaning that it is essential for human function but that our body cannot manufacture it Thus it is acquired from dietary sources such as meat eggs soybeans and legumes with a recommended daily intake of 30 mgkgday Amino acids are the building blocks of proteins which are what allow our cells organs and body to maintain structure and function The investigators are interested in whether 2-AAA is increased in the body after consumption of lysine
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None